First Time Loading...

GMO Pepabo Inc
TSE:3633

Watchlist Manager
GMO Pepabo Inc Logo
GMO Pepabo Inc
TSE:3633
Watchlist
Price: 1 379 JPY 2.07% Market Closed
Updated: May 21, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

11B
+1%
Assets
Growth Rates:
1 Year
-8%
3 Years
+38%
5 Years
+86%
7 Years
+126%
10 Years
+192%
9.1B
+0.2%
Liabilities
Growth Rates:
1 Year
-5%
3 Years
+62%
5 Years
+102%
7 Years
+148%
10 Years
+362%
1.9B
+7%
Equity
Growth Rates:
1 Year
-21%
3 Years
-18%
5 Years
+35%
7 Years
+60%
10 Years
+8%

Balance Sheet Decomposition
GMO Pepabo Inc

11B
Assets
9.1B
Liabilities
11B
Assets
9.1B
Liabilities
Current Assets 8.8B
Cash & Short-Term Investments 2.6B
Receivables 2.8B
Other Current Assets 3.3B
Non-Current Assets 2.2B
Long-Term Investments 590.9m
PP&E 853.8m
Intangibles 657.3m
Other Non-Current Assets 141.6m
Current Liabilities 8.1B
Accounts Payable 296.6m
Accrued Liabilities 9.5m
Other Current Liabilities 7.8B
Non-Current Liabilities 1B
Long-Term Debt 600m
Other Non-Current Liabilities 416.7m

Balance Sheet
GMO Pepabo Inc

Rotate your device to view
Balance Sheet
Currency: JPY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2 108
1 157
1 524
1 591
1 802
1 754
2 472
2 371
2 559
2 760
Cash Equivalents
2 108
1 157
1 524
1 591
1 802
1 754
2 472
2 371
2 559
2 760
Short-Term Investments
700
0
0
0
0
0
0
0
0
0
Total Receivables
530
1 136
1 451
1 732
1 879
2 026
2 487
3 055
4 249
2 671
Accounts Receivables
530
1 136
1 451
1 732
1 879
2 026
2 487
2 591
2 315
1 051
Other Receivables
0
0
0
0
0
0
0
464
1 935
1 620
Inventory
0
0
0
2
6
9
4
9
15
8
Other Current Assets
163
781
809
1 033
1 165
1 128
1 686
1 509
2 488
3 129
Total Current Assets
3 501
3 074
3 785
4 358
4 853
4 916
6 649
6 944
9 311
8 569
PP&E Net
186
332
309
298
266
264
321
427
652
843
PP&E Gross
0
0
0
298
266
0
0
0
0
0
Accumulated Depreciation
0
0
0
485
575
0
0
0
0
0
Intangible Assets
234
200
202
245
285
403
477
553
734
675
Goodwill
1
0
0
0
51
0
0
0
0
0
Note Receivable
0
0
16
16
0
0
0
0
0
0
Long-Term Investments
345
391
372
375
536
682
673
860
643
631
Other Long-Term Assets
148
66
87
85
87
106
91
86
95
156
Other Assets
1
0
0
0
51
0
0
0
0
0
Total Assets
4 415
N/A
4 063
-8%
4 770
+17%
5 377
+13%
6 078
+13%
6 372
+5%
8 212
+29%
8 870
+8%
11 436
+29%
10 875
-5%
Liabilities
Accounts Payable
110
138
132
122
148
177
255
272
249
258
Accrued Liabilities
118
134
139
248
353
75
95
23
59
71
Short-Term Debt
0
0
0
0
0
0
0
0
1 200
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
38
90
357
Other Current Liabilities
2 063
2 766
3 261
3 730
3 794
4 323
5 290
5 361
6 840
7 227
Total Current Liabilities
2 291
3 038
3 532
4 100
4 294
4 575
5 640
5 694
8 439
7 914
Long-Term Debt
0
0
0
0
0
0
0
134
281
1 120
Deferred Income Tax
0
4
27
27
50
0
0
62
0
0
Minority Interest
0
0
0
0
0
0
0
23
0
0
Other Liabilities
16
8
26
27
27
27
27
27
27
30
Total Liabilities
2 307
N/A
3 050
+32%
3 585
+18%
4 154
+16%
4 371
+5%
4 602
+5%
5 667
+23%
5 940
+5%
8 747
+47%
9 064
+4%
Equity
Common Stock
160
160
160
160
160
160
262
262
262
262
Retained Earnings
1 841
894
1 081
1 118
1 516
1 773
2 243
2 517
2 501
1 608
Additional Paid In Capital
150
150
150
150
156
160
270
254
257
257
Unrealized Security Profit/Loss
65
64
50
50
119
133
164
230
63
78
Treasury Stock
107
255
255
255
243
456
395
334
394
394
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
2 108
N/A
1 012
-52%
1 185
+17%
1 223
+3%
1 707
+40%
1 770
+4%
2 544
+44%
2 930
+15%
2 689
-8%
1 811
-33%
Total Liabilities & Equity
4 415
N/A
4 063
-8%
4 770
+17%
5 377
+13%
6 078
+13%
6 372
+5%
8 212
+29%
8 870
+8%
11 436
+29%
10 875
-5%
Shares Outstanding
Common Shares Outstanding
5
5
5
5
5
5
5
5
5
5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.